FibroGen, Inc.
FibroGen, Inc., a leading biotechnology company headquartered in the United States, focuses on developing innovative therapies for serious diseases. Founded in 1993, FibroGen has made significant strides in the fields of anaemia, fibrosis, and other critical health conditions, establishing itself as a key player in the biopharmaceutical industry. The company is renowned for its core product, Roxadustat, a novel treatment for anaemia associated with chronic kidney disease, which has garnered attention for its unique mechanism of action. With a strong presence in both the US and international markets, FibroGen continues to expand its portfolio, aiming to address unmet medical needs and improve patient outcomes. The company’s commitment to research and development has positioned it as a notable innovator in the biotechnology landscape.
DitchCarbon Score
How does FibroGen, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
FibroGen, Inc.'s score of 25 is lower than 54% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
FibroGen, Inc.'s reported carbon emissions
FibroGen, Inc., headquartered in the US, currently does not have any publicly available carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges from the company. This lack of data suggests that FibroGen may not have established formal commitments to reduce its carbon footprint or may not have disclosed such information publicly. As a result, it is unclear how FibroGen aligns with industry standards for climate action or what specific initiatives it may be undertaking to address carbon emissions. Without available data or commitments, it is challenging to assess the company's environmental impact or its role in the broader context of corporate climate responsibility.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
FibroGen, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
